Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016

Details for Mechanism ID: 18080
Country/Region: Cameroon
Year: 2016
Main Partner: Columbia University
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $429,825 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Pediatric Care and Support (PDCS) $47,030
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $111,640
Treatment: Adult Treatment (HTXS) $256,776
Treatment: Pediatric Treatment (PDTX) $14,379
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HRH_PRE By Graduates: Midwives 2017 50
HRH_PRE By Graduates: Nurses 2017 50
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 100
HRH_PRE Sum of Graduates disaggregates 2017 100
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,285
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 476
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 2,285
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 476
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 55,561
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 11,584
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 15,983
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 3,332
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 76,114
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 15,868
HTS_TST Service Delivery Point (Facility): Inpatient 2017 5,427
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,410
HTS_TST Service Delivery Point (Facility): Other PITC 2017 477
HTS_TST Service Delivery Point (Facility): Other PITC 2017 122
HTS_TST Service Delivery Point (Facility): Outpatient 2017 40,688
HTS_TST Service Delivery Point (Facility): Outpatient 2017 10,576
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,608
HTS_TST Service Delivery Point (Facility): Pediatric 2017 131
HTS_TST Service Delivery Point (Facility): PMTCT 2017 26,850
HTS_TST Service Delivery Point (Facility): PMTCT 2017 3,272
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,084
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 282
HTS_TST Sum of Aggregated Age/Sex <15 2017 4,570
HTS_TST Sum of Aggregated Age/Sex <15 2017 952
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 71,544
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 14,916
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 76,114
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 15,868
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 45
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 13
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 45
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 13
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,197
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,070
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 479
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 122
PMTCT_ART Already on ART at beginning of current pregnancy 2017 449
PMTCT_ART Already on ART at beginning of current pregnancy 2017 51
PMTCT_ART New on ART 2017 1,219
PMTCT_ART New on ART 2017 80
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 27,763
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,746
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 970
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 76
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 698
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 55
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 107
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 6
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 10
PMTCT_EID Sum of Infant Age disaggregates 2017 1,668
PMTCT_EID Sum of Infant Age disaggregates 2017 131
PMTCT_STAT By: Known positives at entry 2017 714
PMTCT_STAT By: Known positives at entry 2017 53
PMTCT_STAT By: Number of new positives identified 2017 1,042
PMTCT_STAT By: Number of new positives identified 2017 84
PMTCT_STAT Number of new ANC and L&D clients 2017 29,226
PMTCT_STAT Number of new ANC and L&D clients 2017 1,838
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 27,763
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,746
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,756
PMTCT_STAT Sum of Positives Status disaggregates 2017 137
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 337
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 66
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 13
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 343
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 68
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 699
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 138
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 699
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 138
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 390
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,527
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 1,222
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 312
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 305
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 78
TB_SCREENDX Screen Result: Screened Positive for TB 2017 488
TB_SCREENDX Screen Results: Screened Positive for TB 2017 1,906
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 45
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 45
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 4,197
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 1,070
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 479
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 122
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 13
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 13
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 4,766
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 1,218
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 374
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 74
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 15
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 381
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 76
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 777
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 154
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 863
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 171
TX_CURR Aggregated Age/Sex: <15 Female 2017 94
TX_CURR Aggregated Age/Sex: <15 Female 2017 53
TX_CURR Aggregated Age/Sex: <15 Male 2017 71
TX_CURR Aggregated Age/Sex: <15 Male 2017 53
TX_CURR Aggregated Age/Sex: 15+ Female 2017 5,486
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,929
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,019
TX_CURR Aggregated Age/Sex: 15+ Male 2017 623
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,670
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 2,658
TX_CURR Sum of Aggregated Age/Sex <15 2017 165
TX_CURR Sum of Aggregated Age/Sex <15 2017 106
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,505
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 2,552
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,670
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 2,658
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 22
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 11
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 27
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 36
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 3,691
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,096
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 219
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 882
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,353
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,631
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,631
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,353
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 767
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 265
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 693
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 239
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 4
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 3
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 4
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 3
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 504
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 171
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 181
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 62
TX_PVLS Numerator: Indication: Routine 2017 658
TX_PVLS Numerator: Indication: Routine 2017 227
TX_PVLS Numerator: Indication: Targeted 2017 35
TX_PVLS Numerator: Indication: Targeted 2017 12
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 5
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 3
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 5
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 3
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 560
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 190
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 197
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 69
TX_PVLS_den Denominator: Indication: Routine 2017 688
TX_PVLS_den Denominator: Indication: Routine 2017 239
TX_PVLS_den Denominator: Indication: Targeted 2017 79
TX_PVLS_den Denominator: Indication: Targeted 2017 26
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 28
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 28
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,170
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 631
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 782
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 229
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 3,008
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 880
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,631
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,353
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 27
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 38
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 27
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,672
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,097
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 895
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 219